Linker, R. A., L. De-Hyung, A.-C. Flach, T. Litke, J. van den Brandt, H. M. Reichardt, T. Lingner, U. Bommhardt, M. Sendtner, R. Gold, A. Flügel and F. Lühder: Thymocyte-derived BDNF influences T-cell maturation at the DN3/DN4 transition stage. In: European Journal of Immunology 45, 1326-1338 (2015).
Linker, R. A., P. Brechlin, S. Jesse, P. Steinacker, D. H. Lee, A. R. Asif, O. Jahn, H. Tumani, R. Gold and M. Otto: Proteome profiling in murine models of multiple sclerosis : Identification of stage specific markers and culprits for tissue damage. In: PLoS One 4, 10, Seq. No.: e7624 (2009).
doi: 10.1371/journal.pone.0007624
Herrero-Herranz, E., L. A. Pardo, R. Gold and R. A. Linker: Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis : implications for multiple sclerosis. In: Neurobiology of Disease 30, 162-173 (2008).
doi: 10.1016/j.nbd.2008.01.001
Ehrenreich, H., B. Fischer, C. Norra, F. Schellenberger, N. Stender, M. Stiefel, A.-L. Siren, W. Paulus, K.-A. Nave, R. Gold and C. Bartels: Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. In: Brain 130, 2577-2588 (2007).
Herrero-Herranz, E., L. A. Pardo, G. Bunt, R. Gold, W. Stühmer and R. A. Linker: Re-expression of a developmentally restricted potassium channel in autoimmune demyelination - Kv1.4 is implicated in oligodendroglial proliferation. In: American Journal of Pathology 171, 2, 589-598 (2007).
Wiendl, H., B. C. Kieseier, R. Gold, R. Hohlfeld, M. Bendszus and H. P. Hartung: Revision of McDonald's new diagnostic criteria for multiple sclerosis. In: Nervenarzt 10, 1235-1245 (2006).
Gold, R., H. P. Hartung and R. Hohlfeld: Monoclonal antibodies improve therapy of relapsing multiple sclerosis. Molecular basis and clinical results of anti-VLA4 (natalizumab) therapy.. In: Deutsche Medizinische Wochenschrift 131, 1-2, 31-34 (2006).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.